Catalyst Wire Dossier Catalyst Wire Dossier

Lumiracoxib (Prexige)

lumiracoxib · Novartis
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Lumiracoxib (Prexige), covering 2008-03-18 to 2017-02-07. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Lumiracoxib in Patients With Osteoarthritis and With Controlled Hypertension [Phase 4]

See pricing